Severe delayed autoimmune haemolytic anaemia following artesunate administration in severe malaria: a case report

BACKGROUND: Parenteral artesunate is recommended as first-line therapy for severe and complicated malaria. Although its efficacy has been proven, long-term safety profile is still under evaluation. Several cases of delayed haemolytic anaemia occurred after initial clinical improvement and resolution...

Descripción completa

Detalles Bibliográficos
Autores principales: Raffray, Loic, Receveur, Marie-Catherine, Beguet, Mathilde, Lauroua, Pierre, Pistone, Thierry, Malvy, Denis
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2014
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4203878/
https://www.ncbi.nlm.nih.gov/pubmed/25306236
http://dx.doi.org/10.1186/1475-2875-13-398

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4203878/
https://www.ncbi.nlm.nih.gov/pubmed/25306236
http://dx.doi.org/10.1186/1475-2875-13-398

Ejemplares similares